Improving comfort during epilepsy monitoring
Part of Brain & nervous system clinical trials.
This study tests if changing how we give placebo pills during long hospital monitoring can make the experience better and less stressful for people with epilepsy. The goal is to improve care for those who need this test before epilepsy surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for long-term video-EEG monitoring as part of your epilepsy workup.
- You are able to give your own consent to participate.
- You do not need a legal guardian to make decisions for you.
- You are 18 years or older (or the legal age in your country).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a drug called probenecid can help reduce the number of seizures that happen in a cluster during a hospital stay when your seizure medications are being reduced to record your seizures. The goal is to see if giving probenecid can make the monitoring period safer and more effective for people with focal epilepsy being evaluated for surgery.
This study tests a care program where patients receive remote monitoring and support from a nurse after changing their epilepsy medication. It aims to see if this extra support helps patients manage the change better.
This early research study tests whether a medicine can change the brain’s electrical “rhythms” while people do memory-related tasks. It may help researchers understand how brain timing affects memory in people who are already being evaluated with specialized brain electrode monitoring.
This trial tests a new medication, CB03-154, to see if it is safe and can reduce seizures in adults with focal epilepsy. You may be able to join if you have had focal epilepsy for at least 2 years and are on a stable dose of 1 to 3 anti-seizure medications.
This trial tests XEN1101 compared with a placebo (inactive pill) in people with focal-onset seizures that haven’t been fully controlled despite trying at least two anti-seizure medicines. If you qualify, you may help researchers see whether the study drug reduces seizure frequency and improves control.
This study tests a wearable device that records seizure-related information to understand how epilepsy affects daily life and safety. It may help your care team better track seizures in real-world settings and understand quality-of-life changes.
Hear when a new Symptomatic Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.